Kidron Miriam
SEC CIK 1409232 · EDGAR
BoughtSold
Most active insiders at ORMP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hexter Joshua | COO, CBO | — | $611.4K |
| 2 | Gabay Avraham | CFO | — | $330.7K |
| 3 | Reznick Yehuda | Dir | — | — |
| 4 | Aghion Daniel | Dir | — | — |
| 5 | Shapiro Benjamin | Dir | — | — |
| 6 | Mayer Arie | Dir | — | — |
| 7 | Kidron Miriam | CSO, Dir | — | — |
| 8 | KIDRON NADAV | Pres, CEO, Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2026-03-30 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | F - Tax | $3.31 | -435.1K | 1.13M | -28% | -$1.44M | |
| 2026-03-27 | 2026-03-25 | LFWD | Lifeward Ltd. | Kidron Miriam | Dir | A - Grant | $0.00 | +7,657 | 7,657 | New | $0 | |
| 2026-03-18 | 2026-03-17 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | $0.00 | +119.6K | 1.57M | +8% | $0 | |
| D | 2026-01-29 | 2026-01-22 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | M - OptEx | $0.00 | +19.0K | 1.45M | +1% | $0 |
| 2026-01-21 | 2026-01-14 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | G - Gift | $0.00 | -86.2K | 1.34M | -6% | $0 | |
| DM | 2026-01-05 | 2025-12-31 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | $0.00 | +236.3K | 1.43M | +20% | $0 |
| M | 2025-02-11 | 2025-02-11 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | $0.00 | +192.7K | 1.07M | +22% | $0 |
| 2025-01-06 | 2025-01-02 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | — | +207.0K | 1.00M | +26% | — | |
| 2024-11-08 | 2024-11-07 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO | A - Grant | — | +30.0K | 793.7K | +4% | — | |
| 2024-01-08 | 2024-01-04 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | — | +295.5K | 763.7K | +63% | — | |
| 2023-05-31 | 2023-05-26 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | — | +53.5K | 468.2K | +13% | — | |
| 2023-04-20 | 2023-04-17 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | — | +213.0K | 414.7K | +106% | — | |
| 2023-03-15 | 2023-03-14 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | S - Sale | $2.01 | -100.0K | 201.7K | -33% | -$201.0K | |
| M | 2022-08-01 | 2022-07-28 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | — | +118.0K | 217.7K | +118% | — |
| D | 2022-01-05 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | — | +42.0K | 183.7K | +30% | — |
| 2021-09-02 | 2021-08-31 | ORMP | ORAMED PHARMACEUTICALS INC. | Kidron Miriam | CSO, Dir | A - Grant | — | +66.7K | 141.7K | +89% | — |
Purchase Sale Sale after option exercise All abbreviations